Aeras and China National Biotech Group Partner on TB Vaccine
1/10/2012 11:26:31 AM
January 10, 2012 -- Aeras, a US-based non-profit dedicated to developing effective TB vaccines and biologics, has partnered with the China National Biotec Group (CNBG) to develop a recombinant form of Bacille Calmette-Guerin (BCG), the only TB vaccine currently approved. Aeras will provide financial support and technical expertise to CNBG as part of the partnership. More details...